Transgene Biotek Cash Flow Annual

Trade
BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs
6.58 +0.22 (3.46%)Updated : 18 May 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Net Income/ Starting Line -6.01-10.40-10.43-10.96
Depreciation/ Depletion 4.959.929.919.90
Non- Cash Items 0.010.050.090.21
Changesin Working Capital 1.050.520.451.00
Cashfrom Operating Activities 0.000.100.010.14
Capital Expenditures -0.010.00-0.03-
Other Investing Cash Flow Items Total 0.00-0.10-0.00
Cashfrom Investing Activities -0.01-0.10-0.030.00
Issuance( Retirement)of Debt Net 0.000.00--0.20
Cashfrom Financing Activities 0.000.000.00-0.20
Net Changein Cash -0.010.00-0.01-0.06
Issuance( Retirement)of Stock Net --0.00-
Financing Cash Flow Items ---0.00
Cash Interest Paid ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,506.95+61.75(2.53%)
1,419.00+7.25(0.51%)
9,846.55-44.20 (-0.45%)
2,505.00-9.45 (-0.38%)
HomeMarketsPremiumFor youGet App